Global MedTech Compliance Conference 2015

1. DRAFT AGENDA
1
19-21 May 2015
Athens Hilton
Athens, Greece
2015 Global MedTech Compliance Conference, Athens
19-21 May
DAY TIME PROGRAM
TUESDAY
19 May
08.00 – 17.00 Global Medical Technology Alliance (GMTA)
(Parallel session) - Members only
(Thalia 1)
10.00 – 17.00 Greek Distributor Training (SEIV) – Open session requiring separate
registration (in Greek) (Parallel session)
(Thalia 2&3)
10.00 – 12.30 AdvaMed Device and Diagnostics Compliance Group (DDCG)
(Parallel session) - Members only
(Hesperides)
10.00 – 12.30 MedTech Europe Compliance Network (CN)
(Parallel session)- Members only
(Santorini)
12.30– 13.45 Joint DDCG-CN-GMTA-SEIV Lunch
(Terpsichore D)
13.45 – 17.00 Joint DDCG-CN Session - Members only
(Santorini)
18.00 – 19.30 PwC Compliance Achievement Award & Networking Cocktail
(Galaxy Room)
DAY TIME PROGRAM
WEDNESDAY
20 MAY
07.30 Registration and welcome coffee
(Terpischore Pre Function Room)
09.00 – 09.30 Opening session (Terpsichore AB)
‐ Associations CEOs Panel i.e. Steve Ubl - AdvaMed, Serge
Bernasconi - MedTech Europe & Paul Arnaoutis – SEIV
(confirmed)
09.30 – 9.50 Welcome address
09.50 – 10.45 Plenary session: Anti-corruption, business ethics, innovation &
partnerships: A governmental perspective ( Terpsichore AB)
‐ Candice Welsch, Chief, Implementation Support Section
Corruption and Economic Crime Branch
United Nations Office on Drugs and Crime (confirmed)
Moderator: tbc
Panel Description: Discussion with international organisations and
governmental officials on the value of public-private partnerships to
fight corruption, including views on anti-corruption best practices

2. DRAFT AGENDA
2
19-21 May 2015
Athens Hilton
Athens, Greece
and current trends.
10.45 – 11.15 Networking break
(Convention Level and the Erato Terrace)
11.15 – 12.30 Parallel session 1: Expert panel on distributor-related issues: “How
Would Experts Manage this Distributor Compliance Scenario
(Thalia 123)
‐ Bronwen Taylor, VP, Compliance & Risk Management,
Stryker Corporation
‐
Moderator: tbc
Panel Description: Senior compliance officers will be invited to
discuss and comment on a hypothetical roll-out scenario relating to
the topic of distributors.
11.15 – 12.30 Parallel session 2: Did Sunshine bring transparency? (Hesperides)
‐ Laure Le Calvé, Avocat associée, LCH (confirmed)
‐ EFPIA (confirmed)
‐ Ann S. Brandt, Partner, HealthCare Appraisers, Inc.
(confirmed)
Moderator: Frederick Robinson, Partner, Norton Rose Fulbright
(confirmed)
Panel Description: Discussion on the latest transparency
developments, and how these initiatives can meet the pre-
determined objectives, and more generally provide value.
11.15 – 12.30 Parallel session 3: Where is the compliance officer profession
headed? (Santorini)
‐ Arthur Muratyan, Secretary General, ETHICS (confirmed)
‐ Kathleen M. Boozang, Associate Dean for Academic
Advancement & Professor of Law, Seton Hall University
School of Law (confirmed)
Moderator: UL (confirmed)
Description: Discussion on the role and the profession of the
Healthcare Compliance Officer. This includes considerations such as
the current and future trends of this professions, its place within the
company, as well as the existing training programs and educational
pathways for Ethics and Compliance practitioners.

3. DRAFT AGENDA
3
19-21 May 2015
Athens Hilton
Athens, Greece
11.15 – 12.30 Parallel session 4: Industry consolidation: What does it mean for
compliance? (Thalia 4)
Moderator: tbc
Description: As the MedTech industry is consolidating at an
unprecedented speed, this session will discuss, what does it mean
practically for the compliance function and what are the pitfalls in
deal-making that should be avoid (e.g. before-during-after, re-
consolidation, rebates, competition law).
12.30 – 13.45 Networking Lunch
(Terpsichore D)
13.45 – 15.15 "Coffee Talk": Get Your National Update, and Discuss the Latest
Developments with Your Peers (requires participant selection at the
time of registration, limited to 10 per table) (Thalia 1 2 and 3)
Moderator: Mike Koon, Partner, Norton Rose Fulbright (confirmed)
‐ Brazil:
‐ Colombia:
‐ China:
‐ Denmark:
‐ Greece:
‐ Middle East region:
‐ India:
‐ Russia: David Smith, Executive Director, Fraud Investigation
& Dispute Services, EY (Russia) (confirmed)
‐ Poland & Eastern Europe:
‐ France: Laure Le Calvé, Avocat associée, LCH (confirmed)
‐ Spain & Southern Europe
‐ USA
‐ Australia/Japan
‐ Europe:
‐ International Fair-Market Value: Ann S. Brandt, Partner,
HealthCare Appraisers, Inc. (confirmed)
15.15 – 15.45 Networking break
(Convention Level and the Erato Terrace)
15.45 – 16.00 “Public Perception and Media”? Views on MedTech business ethics
(Terpsichore AB)

4. DRAFT AGENDA
4
19-21 May 2015
Athens Hilton
Athens, Greece
16.00 – 17.00 Plenary session: CEO Roundtable on Global Compliance
(Terpsichore AB)
‐ Stefan Wolf, EDMA Board member & CEO for the HHS
Business Unit, Siemens Healthcare Diagnostics (confirmed)
‐ Jeff Dunn, President and CEO, SI-Bone (confirmed)
‐ Mike Mussallem, Chairman & CEO, Edwards Lifesciences
Corporation (confirmed)
Moderator: Ted Acosta, Partner, Ernst & Young (invited)
Description: In this session, business leaders will provide their
thoughts on what the industry is going through right now in the field
of ethics and compliance (e.g. transparency, consolidation, phasing
out of direct sponsorship). This session also provide the "tone at the
top", illustrating the support of business leaders to the legal and
compliance community, commenting on the role of trade
associations in this field of ethics and compliance as well as
providing the opportunity to explain what they would like to see in
terms of compliance in their company.
18.30 – 20.00 Cocktail Reception (TBD)
THURSDAY
21 May
07.00 Registration
(Terpischore Pre Function Room)
08.45 – 10.00 Plenary session: Direct sponsorship of HCPs to third-party
organized conferences: Global trends and challenges
(Terpsichore AB)
Moderator: PwC (confirmed)
Description: Direct sponsorship, i.e. the provision of financial
support to healthcare professionals (“HCPs”) by healthcare
companies to attend passively third-party medical education
conferences has been a topic of significant importance. Direct
sponsorship is not allowed in certain countries and it is a big topic in
all the other countries, some of them taking different measures to
limit or prohibit various forms of sponsorship. In light of this fast-
changing environment, the discussion will examine the subject in
detail and to try to identify the challenges ahead, when direct
sponsorship will not be possible anymore.

5. DRAFT AGENDA
5
19-21 May 2015
Athens Hilton
Athens, Greece
10.00-11.00 Plenary session: Exchange of best practices: Meeting the challenges
of the transition towards an “indirect-only-sponsorship” model
(Terpsichore AB)
‐ Danie du Plessis, Senior Vice President, Medical
International, GSK (confirmed)
‐ Linda Sneddon, Compliance MPD EMEA, WL Gore &
Associates (confirmed)
‐ Anthony McQuillan, EMEAC Legal & Compliance, Vice
President, Medtronic (confirmed)
Moderator: tbc
Description: With industry planning to move out of direct
sponsorship across the world and more particularly in Europe, China
and Brazil, there are many challenges that need to be addressed in
order to ensure a smooth transition. Such challenges include e.g.
how to continue to support medical education, how to communicate
to customers, how to set up good processes for managing the
compliance risks existing with indirect sponsorship, etc. and will be
discussed in this session.
11.00 -11.30 Networking break
(Convention Level and the Erato Terrace)
11.30 -12.35 Parallel session 1: Local implementation of the EDMA/Eucomed
“Direct Sponsorship Phase-out” recommendation: Challenges for
national associations in Europe
(Thalia 1,2,3)
‐ Anna Lefevre Skjöldebrand, CEO, Swedish Medtech &
Chairwoman of the Eucomed National Associations
Network (confirmed)
‐ Gerry Livadas, General Secretary, SEIV (confirmed)
‐ Lorenzo Fracassi, Consigliere Delegato, Dasit Group
S.p.A. & Member of the EDMA Board (confirmed)
Moderator:
Description: The EDMA ExeCo and Eucomed Board recommendation
to phase out direct sponsorship by the end of 2017 has important
implications for, and raises many concerns from, the national
associations, whose membership is much broader than the
EDMA/Eucomed membership, including many SMEs. Moreover, the
economic circumstances in some of the countries create a situation
where HCPs need the financial support from industry in order to
receive the necessary continuing medical education. Such challenges

6. DRAFT AGENDA
6
19-21 May 2015
Athens Hilton
Athens, Greece
and how to overcome them will be discussed in this session.
11.30 -12.35 Parallel session 2: Indirect Sponsorship and new approaches to
third-parties: What are the options and what’s ahead? (Hesperides
Room)
Moderator: Robert McCully, Partner, Shook, Hardy and Bacon
(confirmed)
Description: This session will discuss how to organize the financial
support to third-parties and how to manage grants in order to avoid
new corruption risks and existing pitfalls.
11.30 -12.35 Parallel session 3: How to organize the communication to
customers? Communicating new support structures to HCPs
(Santorini)
‐ Rick Peterson, General Counsel, AAOS (confirmed)
Moderator: tbc
Description: The panel will be discussing the challenges and
exchange best practices how to communicate effectively, the
changes brought in compliance objectives.
11.30 -12.35 Parallel session 4: Best practices in distributors due diligence
(Thalia 4)
Moderators: Red Flag (invited)
Description:
12.35 -13.35 Networking Lunch
(Terpsichore D)
13.35 – 14.50 Plenary session: Moving to new models of support for medical
education: Considerations from physicians and scientific societies
(Terpsichore AB)
‐ Karen Hackett, CEO, AAOS (confirmed)
‐ Isabel Bardinet, CEO, ESC (confirmed)
Moderator: Skye Potesta, Medical Director, Advanced Surgical
Device Division, Smith & Nephew (invited)
Description: Discussion with scientific societies on how the changing
compliance landscape affects continuing medical education of
healthcare professionals (HCPs) and how to ensure that HCPs around

7. DRAFT AGENDA
7
19-21 May 2015
Athens Hilton
Athens, Greece
the world continue to have access to the education they need.
14.50 – 15.00 Closing remarks (Terpsichore AB)
Sinéad Keogh, Director, Irish Medical Devices Assosication (IMDA)
(confirmed)
15.00 Adjournment